15
Aug
Mumbai (Maharashtra) [India], August 14: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE: 531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational performance during the year through improved efficiencies, focused execution, and a customer-centric approach across its business segments, and has announced its Unaudited Financial Results for Q1 FY27.K Key Consolidated Financial Highlights Highlights Q1 FY27: Total Income of ₹239.90 Mn, YoY growth of 33.81% EBITDA of ₹43.21 Mn, YoY growth of 61.04% EBITDA Margin of 18.01%, YoY growth of 305 Bps Net Profit of ₹24.91 Mn, YoY growth of 43.94% Net Profit Margin of 10.38%, YoY growth…
